SEC Form 4 · accession 0001645627-18-000018
ENDONOVO THERAPEUTICS, INC. · ENDV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Scott Mann
Officer — President · 10% Owner
Period of report
Mar 27, 2018
Accepted (ET)
Apr 3, 2018 · 4:39 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 27, 2018 | P | 2,000 | $0.0339 | A | 24,905,689 | D | |
| Common Stock | Mar 27, 2018 | P | 2,000 | $0.0339 | A | 24,907,689 | D | |
| Common Stock | Mar 27, 2018 | P | 1,000 | $0.0337 | A | 24,908,689 | D | |
| Common Stock | Mar 27, 2018 | P | 1,000 | $0.0329 | A | 24,909,689 | D | |
| Common Stock | Mar 27, 2018 | P | 1,000 | $0.033 | A | 24,910,689 | D | |
| Common Stock | Mar 27, 2018 | P | 2,000 | $0.0329 | A | 24,912,689 | D | |
| Common Stock | Mar 27, 2018 | P | 1,000 | $0.0327 | A | 24,913,689 | D | |
| Common Stock | Mar 27, 2018 | P | 1,000 | $0.0329 | A | 24,914,689 | D | |
| Common Stock | Mar 28, 2018 | P | 1,000 | $0.0339 | A | 24,915,689 | D | |
| Common Stock | Mar 28, 2018 | P | 1,000 | $0.0338 | A | 24,916,689 | D | |
| Common Stock | Mar 28, 2018 | P | 1,000 | $0.0333 | A | 24,917,689 | D | |
| Common Stock | Mar 28, 2018 | P | 1,000 | $0.0332 | A | 24,918,689 | D | |
| Common Stock | Mar 28, 2018 | P | 1,000 | $0.032 | A | 24,919,689 | D | |
| Common Stock | Mar 29, 2018 | P | 1,000 | $0.0379 | A | 24,920,689 | D | |
| Common Stock | Mar 29, 2018 | P | 1,000 | $0.0374 | A | 24,921,689 | D | |
| Common Stock | Mar 29, 2018 | P | 1,000 | $0.0374 | A | 24,922,689 | D |
Table II — derivative securities
No Table II lines on this filing.